A Phase I Pharmacokinetics and Pharmacodynamic Study of GTI2040 in Combination With Gemcitabine in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2015
At a glance
- Drugs Gemcitabine (Primary) ; LOR 2040 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Aug 2005 New trial record.